Citius Pharmaceuticals Announces Nomination of Pharmaceutical Executive Robert J. Smith to its Board of Directors

January 23, 2024

https://www.prnewswire.com/news-releases/citius-pharmaceuticals-announces-nomination-of-pharmaceutical-executive-robert-j-smith-to-its-board-of-directors-302041672.html

Independent Director nominee expected to be elected at Annual Shareholders’ Meeting in March 2024

CRANFORD, N.J., Jan. 23, 2024 /PRNewswire/ — Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products today announced the nomination of seasoned pharmaceutical executive Robert J. Smith to its Board of Directors. The nomination of Mr. Smith is subject to shareholder approval at the Citius Annual Shareholders’ Meeting to be held on March 12, 2024. Upon approval, the Citius Board of Directors will consist of seven members.

Read more at prnewswire.com

Related news for (CTXR)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.